Selection and transplantation of autologous CD34+ B-lineage negative cells in advanced-phase multiple myeloma patients: A pilot study

British Journal of Haematology

Volumn 107, Issue 2, 1999, Pages 419-428

  Lemoli, Roberto M ^a,c   Martinelli, Giovanni ^a   Olivieri, Attilio ^b   Motta, Maria Rosa ^a   Rizzi, Simonetta ^a   Terragna, Carolina ^b   Leopardi, Giuliana ^a   Benni, Monica ^a   Ronconi, Sonia ^b   Cantori, Isabella ^b   Rondelli, Damiano ^a   Mangianti, Serena ^a   Leoni, Pietro ^b   Montanari, Mauro ^a   Cavo, Michele ^a   Tura, Sante ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^c Institute of Hematology and Medical Oncology Seragnoli   (Italy)

Author keywords

Autologous transplantation; CD34+ cells; Multiple myeloma; Positive negative selection; Purging

Indexed keywords

CD34 ANTIGEN;

ADULT; APHERESIS; ARTICLE; AUTOTRANSPLANTATION; CELL LINEAGE; CLINICAL ARTICLE; FEMALE; FLOW CYTOMETRY; HUMAN; MALE; MUCOSA INFLAMMATION; MULTIPLE MYELOMA; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD34; B-LYMPHOCYTES; FEMALE; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LYMPHOCYTE DEPLETION; MALE; MIDDLE AGED; MULTIPLE MYELOMA; NEOPLASM, RESIDUAL; PILOT PROJECTS; TRANSPLANTATION, AUTOLOGOUS;

EID: 0032708335     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1999.01691.x     Document Type: Article

References (37)

1. Alexanian, R., Dimopolous, M.. Smith, T., Delasalle, K., Barlogie, B. & Champlin, R. (1994) Limited value of myeloablative therapy for late multiple myeloma. Blood, 83. 512-516.
2. + Thy-l+Lm~ hematopoietic stem cells (HSC) transplantation in multiple myeloma: a European study. (Abstract). Blood, 90, (Suppl. 1), 394a.
3. Attal, M., Harousseau, J.L., Stoppa, A.M., Sotto, J.J., Fuzibet, J.G., Rossi, J.F., Casassus, P., Maisonneuve, H., Façon, T., Ifrah, N., Payen, C. & Bataille, R. (1996) A prospective randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. New England Journal of Medicine, 335, 91-97.
4. Bataille, R. & Harousseau, J.L. (1997) Multiple myeloma. New England Journal of Medicine, 336, 1657-1664.
5. Bensinger, W.I. (1998) Should we purge? Bone Afarroiv Transplantation. 21. 113-115.
6. Bensinger, W.I., Ron-ley, S.D., Demirer, T., Lilleby, K., Schiffman, K., Clift, R.A., Appelbaum, F.R., Fefer, A., Barnett, T., Storb, R., Chauncey, T., Maziarz, R.T., Klarnet, J., McSweeney, P., Holmberg, L., Maloney. D.G.. Weaver, C.H. & Buckner, C.D. (1996) High-dose therapy followed by autologous hematopoietic stem cell infusion for patients with multiple myeloma. Journal of Clinical Oncology, 14, 1447-1456.
7. + peripheral blood cells expressing CD38, CD56 and monotypic Ig light chain. Blood, 85, 436-447.
8. Bjorkstrand, B., Ljungman, P., Bird, J.M., Samson, D. & Garthon, G. (1995) Double high-dose chemotherapy with autologous stem cell transplantation can induce molecular remissions in multiple myeloma. Bone Marrow Transplantation, 15, 367-371.
9. Brenner, M.K., Rill, D.R., Moen, R.C., Krance, R.A., Mirro, J., French Anderson, w! & Ihle, J.N. (1993) Gene-marking to trace the origin of relapse after autologous bone-marrow transplantation. Lancet, 341, 85-86.
10. Caligaris Cappio, E, Cavo, M., DeVincentiis, A., Lanata, L., Lemoli, R.M., Majolino, I., Tarella, C.. Zanon, P. & Tura, S. (1996) Peripheral blood stem cell transplantation for the treatment of multiple myeloma: biological and clinical implications. Haematologica, 81, 356-375.
11. Corradini, P., Voena, C., Astolfi, M., Ladetto, M., Tarella, C., Boccadoro, M. & Pileri, A. (1995) High-dose sequential chemoradiotherapy in multiple myeloma: residual tumor cells are detectable in bone marrow and peripheral blood harvests and after autografting. Blood, 85, 1596-1602.
12. Corradini, P., Voena, C., Tarella. C., Astolfi. M.. Ladetto, M.. Palumbo. A., Van Lint, M.T., Bacigalupo, A., Santoro, A., Musso, M., Majolino, L, Boccadoro. M. & Pileri, A. (1999) Molecular and clinical remissions in multiple myeloma: role of autologous and allogeneic transplantation of hematopoietic cells. Journal of Clinical Oncology, 17, 208-215.
13. Chronic Leukemia-Myeloma Task Force, National Cancer Institute (1973) Proposed guidelines for protocol studies. II. Plasma cell myeloma. Cancer Chemotherapy Reports. 4, 724-728.
14. Deane, M. & Norton, J.D. (1991) Immunoglobulin gene 'fingerprinting': an approach to analysis of B lymphoid clonality in lymphoproliferative disorders. British Journal of Haematologij, 77, 274-281.
15. + cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML. Blood, 83, 3068-3076.
16. Fogli, M., Amabile, M., Martinelli, G., Fortuna, A., Ratta, M., Rondelli, D., Tura, S. & Lemoli, R.M. (1998) Selective expansion of normal haemopoietic progenitors from chronic myelogenous leukaemia marrow. British Journal ofHaematology, 101, 119-129.
17. Freytes, C.O., Stewart, A.K., Vescio, R., Schiller, G., Ballester, 0., Noga, S., Rugo, H., Stadmauer, E., Sahebi, E, Tarantolo, S., Stiff, P., Mehachard, J., Schlossman, R., Brown, R., TuIIy, H., Jacobs, C., Dipersio, J., Anderson, K., Berenson, J. & Sing, A. (1998) CD34 selection did not delay immune recovery nor increase frequency of infections in multiple myeloma patients transplanted on a phase III trial. (Abstract). Blood, 92, (Suppl. 1). 660a.
18. + stem cells do not contain clonal myeloma cells. Blood, 86, 381-389.
19. Gazitt, Y., Tian, E., Barlogie, B., Reading, C.C., Vesole, D., Jagannath, S., Schnell, J., Hoffman, R. & Tricot, G. (1996) Differential mobilization of myeloma cells and normal hematopoietic stem cells in multiple myeloma following treatment with cyclophosphamide and GM-CSF. Blood, 87, 805-811.
20. Gribben. J.G., Freedman, A.S., Neuberg, D., Roy, D.C., Blake, K.W.. Woo, S.D., Grossbard, M.L., Rabinowe, S.N., Coral, F., Freeman, G.J.. Ritz, J. & Nadler, L.M. (1991) Immunologie purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma. New England Journal of Medicine, 325, 1525-1533.
21. Harousseau, J.L., Altai, M., Divene, M., Marit, G., Leblond, V, Stoppa, A.M., Bourhis, J.H., Caillot, D., Boasson, M., Abragall, J.F., Façon, T., Linassier, C., Cahn, J.Y., Lamy, T., Troussard. X.. Gratecos, N.. Pignon, B., Auzanneau, G. & Bataille, R. (1995a) Autologous stem cell transplantation after first remission induction treatment in multiple myeloma: a report of the French Registry on Autologous Transplantation in Multiple Myeloma. Blood, 85, 3077-3085.
22. Harousseau, J.L., Altai, M., Divine, M., Milpied. N., Marit, G., Leblond, V., Stoppa, A.M., Bourhis. J.H., Caillot, D., Boasson, M., Abragall, J.F., Façon, T., Colombat, P., Cahn, J.Y., Lamy. T., Troussard, X., Gratecos, N., Pignon, B. & Auzanneau, G. (1995b) Comparison of aulologous bone marrow Iransplantation and peripheral blood slem cell transplanlation after first remission induction treatment in multiple myeloma. Bone Marrow 7ra;isplantation. 15, 963-965.
23. Laporte, J.P., Douay, L., Lopez, M., Labopin, M., Jouet, J.P., Lesage, S., Stachowiak, J., Fouillard. L., Isnard, F., Noel-Walter, M.P., Pene, F., Deloux, J., Van Den Akker, J., Grande. M., Bauters, F., Najman, A. & Gorin, N.C. (1994) One hundred twenty-five adult patienls with primary acute leukemia autografted with marrow purged by mafosfamide: a 10-year single institution experjence. Blood. 84, 3810-3818. .
24. + cells to remove circulating tumor cells. .P.'."Ai. 87, 1625-1634.
25. + cells for patients with multiple myeloma. Leukemia and Lymphoma, 26, (Suppl. 1), 1-11.
26. + cells mobilized into peripheral blood of healthy donors by recombinant human granulocyte colony-stimulating factor. Blood. 89, 1189-1196.
27. Martinelli, G., Zaccaria, A., Farabegoli, P., Buzzi, M., Testoni, N.. Bragliani, M., Panzica, G. & Tura, S. (1993) Structural organization of bcr/abl gene in chronic phase and blast transformation in chronic mycloid leukemia patients. Leukemia and Lyinphoma, 11, 51-56.
28. Pilarski, L.M. & Belch, A.J. (1994) Circulating monoclonal B cells expressing P-glyco'protein may be a reservoir of multidrug resistant disease in multiple myeloma. Blood, 83, 724-736.
29. Pilaski, L.M. & Jensen, G.S. (1992) Monoclonal circulating B cells in multiple myeloma: a continuously differentiating possibly invasive population as defined by expression of CD45 isoforms and adhesion molecules. Hematology/Oncology Clinics of North America, 6, 297-332.
30. + peripheral blood progenitor cells after high-dose chemotherapy for patients with advanced multiple myeloma. Blood. 86, 390-397.
31. Stewart, A.K., Vescio, R., Schiller, G., Ballester, 0., Noga, S., Rugo, H., Freytes, C., Stadmauer, E., Sahebi, F., Tarantolo, S., Stiff, P., Meharchand, J., Schlossman, R., Broun, R., Tully, H., Sing. A., Jacobs, C., Dipersio, ]., Anderson, K. & Berenson, J. (1998) Phase III study evaluating CD34 selected versus unselected autologous peripheral blood progenitor cell transplantation in 190 patients with advanced multiple myeloma. (Abstract). Blood, 92, (Suppl. 1), 662a.
32. + cells in the blood of patients with multiple myeloma express CD19 and IgH mRNA and have patientspecific IgH VDJ gene rearrangements. Blood, 89, 1824-1833.
33. Tricot, G., Gazzit, Y., Leemhuis, T., Jagannath, S., Desikan, K.R., Siegel, D., Passas, A.. Tindle, S., Nelson, J., Juttner, C., Tsukamoto, A., Hallaghan, J., Atkinson. K.. Reading. C., Huffman, R. & Barlogie, B. (1998) Collection, tumor contamination and engraftment kinetics of highly purified hematopoietic progenitor cells to support high-dose therapy in multiple myeloma. Blood, 91.44894495.
34. Tricot, G., Jagannath. S., Vesole, D., Nelson, J., Tindle, S., Miller, L., Cheson, B., Crowlcy, B. & Barlogie, B. (1995) Peripheral blood stem cell transplants for multiple myeloma: identification of favorable variables for rapid engraftment in 225 patients. Blood, 85, 588-596.
35. van Dongen, J.J., Breit, T.M., Adriaansen, H.J., Beishvizen, A. & Hooijkaas, M. (1992) Detection of minimal residual disease in acute leukemia by immunological marker-analysis and polymerase chain reaction. Leukemia, 6, 47-59.
36. Vesole, D.H.. Barlogie, B., Jagannath, S., Cheson, B., Tricot, G., Alexanian, R. & Crowley, J. (1994) High-dose therapy for refractory multiple myeloma: improved prognosis with better supportive care and double transplants. Blood, 84, 950-956.
37. Vesole, D.H., Tricot, G., Jagannath. S., Desikan, K.R., Siegel, D., Bracy, D., Miller, L., Cheson, B., Crowley, J. & Barlogie. B. (1996) Autotransplants in multiple myeloma: what have we learned? Blood. 88, 838-847.